FEATURED ARTICLES & COMMENTARY
The People Issue 2019: Nineteen individuals who make life in D.C. more interesting tell us their stories-Washington City Paper
Don't Let Them Put Anything Inside You: The Complex Family Planning Considerations of Women from Marginalized and Disenfranchised Communities- Population Connection magazine
Serena Williams' Childbirth Experience Should Be a Wake-up Call About the Medical Treatment New Moms Are Getting—Especially Women of Color- Glamour.com
She Had A Stillborn Baby. She Faults An Ambulance Delay -Washington City Paper
What Generic Mifepristone Means For People Seeking Abortions, According To Experts & Advocates- Bustle
As Abortion Access Shrinks, People Turn To Imported Pills- Bloomberg Law
This Abortion Provider Appreciation Day, Get to Know the People Who Make Abortion Care Possible-Rewire.News
Trump Nominates Kavanaugh for Supreme Court-Medpage Today
Tennessee Observes First Ever Black Maternal Health Week- Tennessee Public News Service
The Senate is about to vote on a bill that will devastate women and gender minorities' health care-ThinkProgress.org
Peer Reviewed Publications
Shakir-Reese JM, Ye P, Perritt JB, Lotke P, Reeves M. A factorial-design randomized controlled trial comparing misoprostol alone to Dilapan with misoprostol and comparing buccal to vaginal misoprostol for same-day cervical preparation prior to dilation & evacuation at 14 weeks 0 days–19 weeks 6 days gestation. Contraception. 2019 Dec; 100(6) 445-450
Casey FE, Ye P, Perritt JB, Moreno-Ruiz N, Reeves MF. A randomized controlled trial evaluating same-day mifepristone and misoprostol compared to misoprostol alone for cervical preparation prior to second-trimester surgical abortion. Contraception. 2016 March;94(2) 127-133.
Perritt JB, Burke A, Edelman AB. Clinical Guidelines: Interruption of nonviable pregnancies of 24-28 weeks’ gestation using medical methods. Contraception. 2013 Sept; 88(3) 341-349.
Perritt JB, Burke AE, Jamshidi J, Wang J, Fox M. Contraception counseling, pregnancy intention, and contraception use in women with medical problems: an analysis of data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS). Contraception.2013; 88(2) 263-268
Perritt JB, Edelman AB, Burke AE. Controversies in family planning: management of lethal fetal anomalies in the third trimester. Contraception. 2012 Aug; 86(2)93-95.